Andere talen MAIA Biotechnology, Inc.

Aandelen

MAIA

US5526411021

Beurs gesloten - Nyse Andere beurzen 22:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,42 ^USD	+2,70%		+8,57%	+192,31%

07/06	MAIA Biotechnology's Telomeer Targeting Functionaliteit is aantoonbaar levensvatbaar door goedkeuring door de FDA van een therapie met telomeraseremmers	CI
04/06	Maia Biotechnology onthult nieuwe klinische gegevens die de sterke werkzaamheid van Thio in niet-kleincellige longkanker aantonen	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Pioneering Cancer Treatment: the Successful Partnership Between MAIA Biotechnology and Cromos Pharma	22/06
MAIA Biotechnology Shares Rise After FDA's Telomerase Inhibitor Approval Shows Viability of Such Therapies	07/06
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy	07/06
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA?s Approval of a Telomerase Inhibitor Agent Therapy	07/06
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent	06/06
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer	06/06
MAIA BIOTECHNOLOGY REVEALS NEW CLINICAL DATA SHOWING THIO'S STRONG EFFICACY IN NON-SMALL CELL LUNG CANCER	05/06
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer	04/06
Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer	04/06
MAIA Biotechnology : Poster (June 2024)	03/06
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	21/05
MAIA Biotechnology, Inc. announced a financing transaction	21/05
MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024	20/05
MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2024 ANNUAL MEETING	17/05
MAIA Biotechnology to Present at the BIO International Convention 2024	17/05
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting	16/05
MAIA Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement	30/04
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement	29/04
Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	26/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen MAIA Biotechnology, Inc.

Aandelen

MAIA

US5526411021

Andere talen

Filters